NIOGERMOXA&P· BU2027
Every activity itemized under this project, with its own expense type and monthly phasing.
| Activity | GL account | Expense type | Allocation | Original | Current budget | Phased | Status | |
|---|---|---|---|---|---|---|---|---|
| NIOGERMOX Central Project — Patient Journey | Consultancy / Advisory | Central Project | P1 | 574 € | 574 € | Proposed | ||
| NIOGERMOX Market Insight Study | Market Survey | Market Survey / Insight | P2 | 574 € | 574 € | Committed | ||
| Total itemized | 1148 € | 90% | ||||||